Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 68 clinical trials
Featured trial
CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer  

Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving CBM588, nivolumab, …

  • 0 views
  • 14 Mar, 2022
  • 1 location
Supramarginal Resection in Glioblastoma

The current concept in all patients with glioblastoma is "maximum safe resection of the contrast enhancing tumor", but this may in selected cases be extended to simply "maximum safe resection" tailored to the patient and extent of disease at hand. Densely proliferating tumor cells have been found from at an …

malignant glioma
supratentorial glioblastoma multiforme
adjuvant
karnofsky performance status
astrocytoma
  • 0 views
  • 16 Feb, 2024
  • 19 locations
Venetoclax SL-401 and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm

IL-3 attaches to IL-3 receptors on tumor cells in a targeted way and delivers DT to kill them. Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.

hydroxyurea
treatment regimen
blastic plasmacytoid dendritic cell neoplasm
venetoclax
ejection fraction
  • 0 views
  • 16 Feb, 2024
  • 1 location
Study of NK Combined With Chemotherapy for Advanced Solid Tumor

Combinations Natural Killer Cell (NK) With chemotherapy treatment may enhance the immune response and stop cancer cells from growing.

solid tumor
psychiatric disorder
advanced malignant solid tumor
metastasis
brain metastases
  • 0 views
  • 16 Feb, 2024
  • 1 location
Study of DC-CIK Combined With Chemotherapy for Advanced Solid Tumor

Combinations of Dendritic cell-activated cytokine-induced killer cell (DC-CIK) With chemotherapy treatment may enhance the immune response and stop cancer cells from growing.

solid tumor
psychiatric disorder
advanced malignant solid tumor
metastasis
brain metastases
  • 0 views
  • 16 Feb, 2024
  • 1 location
Quantifying Oxygen Utilization of Tumors Using Oxygen-Enhanced Molecular MRI

This trial looks to study the safety and feasibility of using oxygen-enhanced molecular MRI to understand how cancer cells use oxygen differently than normal cells. Cancer cells tend to utilize (or not utilize) oxygen differently than normal cells.

metastasis
neoplasm
brain metastasis
brain metastases
MET
  • 0 views
  • 16 Feb, 2024
  • 1 location
Vertebral Body Sparing Craniospinal Irradiation for Pediatric Patients With Cancer of the Central Nervous System

Intensity modulated proton therapy is an advanced radiation therapy modality that uses high energy protons to kill cancer cells and shrink tumors, and may reduce the side effects of treatment by reducing radiation exposure to the spinal column.

  • 0 views
  • 16 Feb, 2024
  • 2 locations
Chimeric Antigen Receptor T-cells for The Treatment of AML Expressing CLL-1 Antigen

T lymphocytes can kill tumor cells but there normally are not enough of them to kill all the tumor cells. Some researchers have taken T cells from a person's blood, grown more of them in the laboratory and then given them back to the person.

apheresis
hematologic malignancy
pulse oximetry
myeloid leukemia
flow cytometry
  • 0 views
  • 16 Feb, 2024
  • 1 location
Targeting CD276 (B7-H3) Positive Solid Tumors by 4SCAR-276

The 4SCAR-CD276-modified T cells (4SCAR-276) can recognize and kill tumor cells through the recognition of CD276, a surface protein expressed at high levels on many types of tumors but at low levels on normal tissues.

solid tumor
solid neoplasm
serum bilirubin
growth factor
blood transfusion
  • 0 views
  • 16 Feb, 2024
  • 3 locations
Study in Healthy Adult Male Participants to Gather Information How the Human Body Absorbs Distributes and Excretes the Study Drug Selitrectinib Including the Effect of the Interaction of Food With the Study Drug on the Human Body

The drug blocks the action of the NTRK gene fusion and prevents the activation of certain proteins (TRK fusion proteins), which can cause cancer cells to multiply and form a tumor. Researchers also want to find out if the participants have any medical problems during this study.

  • 0 views
  • 16 Feb, 2024
  • 1 location